Items where authors include "Mafirakureva, N."

Article

Dodd, P.J. orcid.org/0000-0001-5825-9347, Mafirakureva, N. orcid.org/0000-0001-9775-6581, Seddon, J.A. et al. (1 more author) (2022) The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study. The Lancet Global Health, 10 (7). E1034-E1044. ISSN 2214-109X

Mafirakureva, N. orcid.org/0000-0001-9775-6581, Klinkenberg, E., Spruijt, I. et al. (9 more authors) (2022) Xpert ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis. BMJ Open, 12 (7). e058388. ISSN 2044-6055

Mafirakureva, N. orcid.org/0000-0001-9775-6581, Stone, J., Fraser, H. et al. (23 more authors) (2022) An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya : a model‐based cost‐effectiveness analysis. Addiction, 117 (2). pp. 411-424. ISSN 0965-2140

Ward, Z., Mafirakureva, N. orcid.org/0000-0001-9775-6581, Stone, J. et al. (7 more authors) (2021) Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison. International Journal of Drug Policy, 96. 103394. ISSN 0955-3959

Dzingirai, B., Katsidzira, L., Matyanga, C.M.J. et al. (3 more authors) (2021) Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges. Journal of Viral Hepatitis, 28 (7). pp. 994-1002. ISSN 1352-0504

Marquez, L.K., Chaillon, A., Soe, K.P. et al. (15 more authors) (2021) Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar. BMJ Global Health, 6 (2). e004181. ISSN 2059-7908

Mafirakureva, N., Lim, A.G., Khalid, G.G. et al. (13 more authors) (2021) Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan. Journal of Viral Hepatitis, 28 (2). pp. 268-278. ISSN 1352-0504

Walker, J.G., Mafirakureva, N., Iwamoto, M. et al. (11 more authors) (2020) Cost and cost‐effectiveness of a simplified treatment model with direct‐acting antivirals for chronic hepatitis C in Cambodia. Liver International, 40 (10). pp. 2356-2366. ISSN 1478-3223

Lim, A.G., Walker, J.G., Mafirakureva, N. et al. (23 more authors) (2020) Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis. The Lancet Global Health, 8 (3). e440-e450. ISSN 2214-109X